Simplexa C. auris Direct
Device
DiaSorin Molecular LLC
Total Payments
$38,003
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $38,003 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $38,003 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| C. Auris IVD Clinical Study (Project DD20-009) Clinical Study | DiaSorin Molecular LLC | $38,003 | 0 |
Top Doctors Receiving Payments for Simplexa C. auris Direct
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $38,003 | 1 |
Ad
Manufacturing Companies
- DiaSorin Molecular LLC $38,003
Product Information
- Type Device
- Total Payments $38,003
- Total Doctors 0
- Transactions 1
About Simplexa C. auris Direct
Simplexa C. auris Direct is a device associated with $38,003 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is DiaSorin Molecular LLC.
Payment data is available from 2024 to 2024. In 2024, $38,003 was paid across 1 transactions to 0 doctors.
The most common payment nature for Simplexa C. auris Direct is "Unspecified" ($38,003, 100.0% of total).
Simplexa C. auris Direct is associated with 1 research study, including "C. Auris IVD Clinical Study (Project DD20-009) Clinical Study" ($38,003).